Novartis

Novartis Cancer Drug Shows Promise as Treatment for Parkinson's
Bloomberg
Mon, 10/19/15 - 09:58 am
Tasigna
Novartis
Parkinson's Disease
Gamida Cell pockets $5M from Novartis ahead of mooted financing round
Fierce Biotech
Fri, 10/16/15 - 07:31 am
Gamida Cell
Novartis
Who's Up Next? More Pharma Companies Expected To Settle Foreign Bribery Cases
Forbes
Wed, 10/14/15 - 02:15 pm
FCPA
bribery
GSK
Bristol-Myers Squibb
Teva Pharmaceutical
Sanofi
AstraZeneca
UCB Pharma
Novartis
Novo Nordisk
Eli Lilly
Novartis pours another $15M into Israeli stem cell company
BioPharma Dive
Tue, 10/13/15 - 06:14 pm
Novartis
Israel
stem cells
Gamida Cell
Advera Health Analytics: Novartis, Allergan Alzheimer's meds linked to abnormal behavior, blood pressure side effects
Fierce Pharma
Sun, 10/11/15 - 01:57 pm
Novartis
Allergan
Alzheimer's disease
Eisai
Exelon Patch
Namenda
Aricept
Glaxo OTC chief: When it comes to consumer health, pharma has the edge
Fierce Pharma Marketing
Wed, 10/7/15 - 09:53 am
GSK
OTC
Novartis
consumer health
A Top Pharma Exec's Warning To Millennial Women: Avoid The Perfection Trap
Forbes
Tue, 10/6/15 - 06:58 pm
Novartis
women
millennials
Christi Shaw
Kidney Cancer Drug Boxing Match
Motley Fool
Mon, 10/5/15 - 09:17 am
kidney cancer
Bristol-Myers Squibb
Novartis
Exelixis
Opdivo
Cometriq
Afinitor
Glaxo's consumer health CEO lays out blueprint for margin turnaround
Fierce Pharma
Sat, 10/3/15 - 02:19 pm
GSK
consumer health
Novartis
Novartis biosimilar copycat takes aim at Amgen's drug Enbrel
Yahoo/Reuters
Fri, 10/2/15 - 10:37 am
Novartis
biosimilar
Amgen
Enbrel
rheumatoid arthritis
Sandoz
Novartis stacks up more data for lucrative Cosentyx expansion
Fierce Pharma
Thu, 10/1/15 - 02:08 pm
Novartis
Cosentyx
psoriasis
Xoma enters exclusive license agreement with Novartis
Marketwatch
Thu, 10/1/15 - 09:40 am
Xoma
Novartis
cancer
antibodies
Novartis CEO: Here's How We'll Get Cheap Medicine To Poor Countries
Forbes
Wed, 09/30/15 - 09:42 am
Novartis
Joe Jimenez
Pharma CEOs
developing countries
Bristol's Opdivo boosts kidney cancer survival beyond two years
Yahoo/Reuters
Sat, 09/26/15 - 09:54 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Novartis
Afinitor
Novartis brings heart, cancer meds to low-income countries for $1 per month
Fierce Pharma
Fri, 09/25/15 - 09:45 am
Novartis
emerging markets
AbbVie Not Worried About Humira Biosimilars
Bidness, ETC
Mon, 09/21/15 - 10:54 am
AbbVie
Humira
biosimilars
Gilead
Pfizer
Novartis
Amgen
Watch out, Afinitor. Bristol's 'breakthrough' Opdivo is coming for you
Fierce Pharma Marketing
Fri, 09/18/15 - 09:14 pm
Bristol-Myers Squibb
Afinitor
Opdivo
Novartis
kidney cancer
An update on first-ever US biosim Zarxio 2 weeks after its debut
BioPharma Dive
Fri, 09/18/15 - 11:42 am
Novartis
Sandoz
Zarxio
bioimilars
Amgen
Neupogen
Novartis will weather the EM market storm: CEO
CNBC
Fri, 09/18/15 - 10:49 am
Novartis
Joe Jimenez
emerging markets
Pharma Deal-Making: In The Pink Of Health
Seeking Alpha
Wed, 09/16/15 - 10:26 am
M&A
Baxalta
GSK
JNJ
Eli Lilly
Novartis
Perrigo
Shire

Pages